results from acis trial of apalutamide abiraterone/prednisone in patients with chemo-naive mcrpc
Published 2 years ago • 451 plays • Length 10:00Download video MP4
Download video MP3
Similar videos
-
4:18
acis trial of apalutamide and abiraterone in chemotherapy-naïve mcrpc
-
1:50
a phase i trial of apalutamide plus abiraterone acetate, docetaxel, and prednisone in mcrpc
-
5:59
apalutamide in combination with abiraterone acetate, docetaxel and prednisone for mcrpc
-
8:33
titan phase 3 trial with apalutamide in metastatic castration sensitive prostate cancer
-
1:20
panther: apalutamide abiraterone in black and white mcrpc patients
-
7:12
abiraterone acetate/prednisone apalutimide and adt post-op srt may improve pfs and mfs
-
1:18
results of the latitude trial in high-risk metastatic hormone-naive prostate cancer
-
17:44
new approaches to metastatic hormone sensitive prostate cancer
-
1:28
apalutamide plus adt leads to survival benefit in mcspc
-
1:55
awaiting key results for enzalutamide and apalutamide in nmcrpc
-
4:56
fred saad, esmo 2022: phase iii propel trial of abiraterone olaparib in prostate cancer
-
1:16
dr. charles ryan on the cou-aa-302 abiraterone acetate interim analysis results
-
2:38
safety outcomes of darolutamide vs apalutamide and enzalutamide in nmcrpc
-
2:50
live from asco: apalutamide for castration-sensitive prostate cancer
-
18:21
decisional tools to determine need for biopsy and re-biopsy in men with elevated psas
-
6:42
titan trial
-
0:44
propel: gene-by-gene efficacy of olaparib and abiraterone in mcrpc
-
2:20
mcrpc case impressions & adt abiraterone response
-
3:38
results from peace-1: abiraterone in mcspc